Integrated analysis identified prognostic microRNAs in breast cancer

被引:0
作者
Cong Shang
Qingyan Chen
Fuqiang Zu
Weidong Ren
机构
[1] Shengjing Hospital of China Medical University,Department of Ultrasound
[2] Shengjing Hospital of China Medical University,undefined
来源
BMC Cancer | / 22卷
关键词
Breast cancer; Risk model; Nomogram; miR-127; Tumor progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 265 条
[1]  
Siegel RL(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
[2]  
Miller KD(2014)Breast cancer in China Lancet Oncol 15 e279-289
[3]  
Fuchs HE(2019)The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer BMC Cancer 19 1091-874
[4]  
Jemal A(2011)Non-coding RNAs in human disease Nat Rev Genet 12 861-437
[5]  
Fan L(2014)The rise of regulatory RNA Nat Rev Genet 15 423-469
[6]  
Strasser-Weippl K(2014)MicroRNAs in cancer: biomarkers, functions and therapy Trends Mol Med 20 460-227
[7]  
Li JJ(2009)MicroRNAs in cancer Annu Rev Pathol 4 199-17
[8]  
St Louis J(2016)Non-coding RNAs: classification, biology and functioning Adv Exp Med Biol 937 3-159
[9]  
Finkelstein DM(2012)MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics A comprehensive review EMBO Mol Med 4 143-1143
[10]  
Yu KD(2015)MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer Theranostics 5 1122-689